Faculty profile

Eva Kaufmann

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Eva Kaufmann

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

116

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Asthma Eosinophils Innate Immune Memory,Preclinical Research,Vaccination

Latest papers

Trained Immunity in Childhood Vaccination.
Acta paediatrica (Oslo, Norway : 1992) · 2026 · senior author
Evolution and development of innate immune memory.
Science immunology · 2026 · senior author
Sensory neuron production of substance P and TAFA4 promotes disease tolerance during viral infection.
Immunity · 2026

All 28 publications

Latest funding

International Conference on Innate Immune Memory
CIHR · 2025 · Co-investigator
$20,000
Trained Immunity in Eosinophils: Mechanisms and Therapeutic Opportunities
CIHR · 2025 · Nominated PI
$50,000

All 2 grants and awards

28 publications.

Trained Immunity in Childhood Vaccination.

Cai C, Hossenbaccus L, Kaufmann E

Acta paediatrica (Oslo, Norway : 1992)2026Senior author

DOI: 10.1111/apa.70751 PMID: 42770653

Evolution and development of innate immune memory.

Divangahi M, Kaufmann E

Science immunology2026Senior author

DOI: 10.1126/sciimmunol.aeb7976 PMID: 42397938

Sensory neuron production of substance P and TAFA4 promotes disease tolerance during viral infection.

Roger A, Fohrer T, Mardelle U, Thomas I, Nezhad ST, Gupta S, Dory A, Jeyanathan V, Liaghat A, Mielle J, Khlifi HM, Santamaria JC, Brunet E, Gouilly J, Escaliere B, Bretaud N, Crosson T, Barbon PV, Mossadegh-Keller N, Irla M, Basta S, Broggi A, Milpied P, Gour N, Feuillet V, Hoeffel G, Dong X, Kaufmann E, Reynders A, Talbot S, Moqrich A, Ugolini S

Immunity2026

DOI: 10.1016/j.immuni.2026.01.022 PMID: 41747735

Basophils activate oncostatin M receptor-expressing vagal sensory neurons.

Wang JC, Park K, Roger A, Nikpoor AR, Crosson T, Sunwoo HJ, Kaufmann E, Rafei M, Chang EH, Talbot S

The Journal of allergy and clinical immunology2026

DOI: 10.1016/j.jaci.2025.10.027 PMID: 41207641

Evolving our understanding of trained immunity.

Kaufmann E, Sohrabi Y, Domínguez-Andrés J, Novakovic B, Netea MG, van der Meer JWM

eLife2025First author

DOI: 10.7554/elife.106029 PMID: 41190945

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via reprogramming granulopoiesis.

Jurado LF, Daman AW, Li Z, Ross VMS, Nikolaou K, Tran KA, Loutochin O, McPherson VA, Prével R, Tarancón R, Couto K, Pernet E, Khan N, Cheong JG, Ramaiah R, Ketavarapu M, Kaufmann E, Glickman MS, Thanabalasuriar A, Josefowicz SZ, Divangahi M

Immunity2025

DOI: 10.1016/j.immuni.2025.05.026 PMID: 40555239

Author Correction: β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Khan N, Tran KA, Chevre R, Locher V, Richter M, Sun S, Sadeghi M, Pernet E, Herrero-Cervera A, Grant A, Saif A, Downey J, Kaufmann E, Khader SA, Joubert P, Barreiro LB, Yipp BG, Soehnlein O, Divangahi M

Nature immunology2025

DOI: 10.1038/s41590-025-02099-6 PMID: 39920361

Characterization of SARS-CoV-2 Entry Genes in Skeletal Muscle and Impacts of In Vitro Versus In Vivo Infection.

Bhattarai S, Kaufmann E, Liang F, Zheng Y, Gusev E, Hamid Q, Ding J, Divangahi M, Petrof BJ

Journal of cachexia, sarcopenia and muscle2025

DOI: 10.1002/jcsm.13705 PMID: 39871399

β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Nature immunology2025

DOI: 10.1038/s41590-024-02041-2 PMID: 39779870

Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.

Grune J, Bajpai G, Ocak PT, Kaufmann E, Mentkowski K, Pabel S, Kumowski N, Pulous FE, Tran KA, Rohde D, Zhang S, Iwamoto Y, Wojtkiewicz GR, Vinegoni C, Green U, Swirski FK, Stone JR, Lennerz JK, Divangahi M, Hulsmans M, Nahrendorf M

Circulation2024

DOI: 10.1161/circulationaha.123.066433 PMID: 38506045

Something wrong or missing on this profile? Suggest a correction

Eva Kaufmann

Research

Latest papers

Latest funding

Trained Immunity in Childhood Vaccination.

Evolution and development of innate immune memory.

Sensory neuron production of substance P and TAFA4 promotes disease tolerance during viral infection.

Basophils activate oncostatin M receptor-expressing vagal sensory neurons.

Evolving our understanding of trained immunity.

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via reprogramming granulopoiesis.

Author Correction: β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Characterization of SARS-CoV-2 Entry Genes in Skeletal Muscle and Impacts of In Vitro Versus In Vivo Infection.

β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.

International Conference on Innate Immune Memory

Trained Immunity in Eosinophils: Mechanisms and Therapeutic Opportunities

Frequent collaborators

Maziar Divangahi

Eva Kaufmann

Jun Ding

Philippe Joubert

Nargis Khan

Bruce Mazer

Anastasia Nijnik

Arinjay Banerjee

Moutih Rafei

Moutih Rafei

Sébastien Talbot

Ajitha Thanabalasuriar

Connie Krawczyk

Erwin Schurr

Luda Diatchenko

Samira Mubareka

Yue Li

Karen Mossman

Eva Kaufmann

Research

Latest papers

Latest funding

Trained Immunity in Childhood Vaccination.

Evolution and development of innate immune memory.

Sensory neuron production of substance P and TAFA4 promotes disease tolerance during viral infection.

Basophils activate oncostatin M receptor-expressing vagal sensory neurons.

Evolving our understanding of trained immunity.

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Gu&#xe9;rin via reprogramming granulopoiesis.

Author Correction: &#x3b2;-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Characterization of SARS-CoV-2 Entry Genes in Skeletal Muscle and Impacts of In&#xa0;Vitro Versus In&#xa0;Vivo Infection.

&#x3b2;-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart.

International Conference on Innate Immune Memory

Trained Immunity in Eosinophils: Mechanisms and Therapeutic Opportunities

Frequent collaborators

Maziar Divangahi

Eva Kaufmann

Jun Ding

Philippe Joubert

Nargis Khan

Bruce Mazer

Anastasia Nijnik

Arinjay Banerjee

Moutih Rafei

Moutih Rafei

Sébastien Talbot

Ajitha Thanabalasuriar

Connie Krawczyk

Erwin Schurr

Luda Diatchenko

Samira Mubareka

Yue Li

Karen Mossman

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via reprogramming granulopoiesis.

Author Correction: β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.

Characterization of SARS-CoV-2 Entry Genes in Skeletal Muscle and Impacts of In Vitro Versus In Vivo Infection.

β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus.